COST

975.98

-0.18%↓

PG

156.8

+0.93%↑

MO

65.16

+1.64%↑

CL

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

PG

156.8

+0.93%↑

MO

65.16

+1.64%↑

CL

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

PG

156.8

+0.93%↑

MO

65.16

+1.64%↑

CL

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

PG

156.8

+0.93%↑

MO

65.16

+1.64%↑

CL

94.31

+1.29%↑

SYY

84.63

+0.01%↑

COST

975.98

-0.18%↓

PG

156.8

+0.93%↑

MO

65.16

+1.64%↑

CL

94.31

+1.29%↑

SYY

84.63

+0.01%↑

Search

USANA Health Sciences Inc

Closed

20.78 2.26

Overview

Share price change

24h

Current

Min

20.32

Max

20.97

Key metrics

By Trading Economics

Income

-17M

-6.7M

Sales

-22M

214M

P/E

Sector Avg

24.067

29.995

EPS

-0.15

Profit margin

-3.118

Employees

1,700

EBITDA

-17M

11M

Dividends

By Dow Jones

Next Earnings

17 Feb 2026

Market Stats

By TradingEconomics

Market Cap

14M

396M

Previous open

18.52

Previous close

20.78

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

USANA Health Sciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Feb 2026, 00:00 UTC

Hot Stocks

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 Feb 2026, 22:55 UTC

Earnings

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 Feb 2026, 21:44 UTC

Earnings

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 Feb 2026, 21:39 UTC

Earnings

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 Feb 2026, 00:00 UTC

Earnings

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 Feb 2026, 00:00 UTC

Earnings

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 Feb 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 Feb 2026, 23:45 UTC

Earnings

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 Feb 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 Feb 2026, 22:59 UTC

Acquisitions, Mergers, Takeovers

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 Feb 2026, 22:30 UTC

Earnings

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 Feb 2026, 22:30 UTC

Earnings

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 Feb 2026, 22:21 UTC

Earnings

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 Feb 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 Feb 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 Feb 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4 Feb 2026, 21:53 UTC

Earnings

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 Feb 2026, 21:51 UTC

Earnings

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 Feb 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 Feb 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

4 Feb 2026, 21:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

4 Feb 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4 Feb 2026, 21:45 UTC

Earnings

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 Feb 2026, 21:44 UTC

Earnings

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 Feb 2026, 21:43 UTC

Earnings

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 Feb 2026, 21:41 UTC

Earnings

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 Feb 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 Feb 2026, 21:30 UTC

Earnings

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 Feb 2026, 21:30 UTC

Earnings

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 Feb 2026, 21:30 UTC

Earnings

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Peer Comparison

Price change

USANA Health Sciences Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

28.405 / 29.84Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat